Establishment of a Korea HPV cohort study

Journal of Gynecologic Oncology

Volumn 24, Issue 1, 2012, Pages 59-65

  Lee, Won Chul ^a   Lee, Sae Young ^a   Koo, Yu Jin ^b   Kim, Tae Jin ^b   Hur, Soo Young ^c   Hong, Sung Ran ^b   Kim, Sung Soon ^d   Kee, Mee Kyung ^d   Rhee, Jee Eun ^d   Lee, Joo Shil ^d   Choi, Ho Sun ^e   Cho, Chi Heum ^f   Kim, Ki Tae ^g   Park, Jong Sup ^c  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d Korea Centers for Disease Control and Prevention   (South Korea)

^e Chonnam National University Medical School   (South Korea)

^f Dongsan Medical Center   (South Korea)

^g Inje University College of Medicine   (South Korea)

Author keywords

Cervical intraepithelial neoplasms; Cohort studies; Human papillomavirus; Uterine cervical neoplasms

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HUMAN; KOREA; LOW GRADE SQUAMOUS INTRAEPITHELIAL LESION; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MULTICENTER STUDY; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; TUMOR GROWTH; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS STRAIN; WART VIRUS;

EID: 84873031026     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2013.24.1.59     Document Type: Article

References (21)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Globocan 2008: cancer incidence and mortality worldwide. Lyon: International Agency for Research on Cancer; 2010.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
3. Korean Cancer Registration and Statistics. Cancer incidence and death, 2009 [Internet]. Goyang: Korea Cancer Registration and Statistics, National Cancer Center; c2012 [cited 2012 Dec 10]. Available from: http://ncc.re.kr/manage/ manage03_033_view.jsp?bbsnum=209&hSelSearch=&hT xtKeyword=¤t_page=1&cd=null.
4. Kim JY, Nam BH, Lee JA. Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histology. J Gynecol Oncol 2011;22:32-8.
5. Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 2008;110:S4-7.
6. Alvarez RD, Wright TC; Optical Detection Group. Effective cervical neoplasia detection with a novel optical detection system: a randomized trial. Gynecol Oncol 2007;104:281-9.
7. Pothisuwan M, Pataradool K, Tangjitgamol S, Srijaipracharoen S, Manusirivithaya S, Thawaramorn T. Visual inspection with acetic acid for detection of high grade lesion in atypical squamous cells and low grade squamous intraepithelial lesions from cervical Pap smear. J Gynecol Oncol 2011;22:145-51.
8. Dunn TS, Burke M, Shwayder J. A "see and treat" management for high-grade squamous intraepithelial lesion pap smears. J Low Genit Tract Dis 2003;7:104-6.
9. Cox JT, Schiffman M, Solomon D; ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188:1406-12.
10. Reid R, Scalzi P. Genital warts and cervical cancer. VII. An improved colposcopic index for differentiating benign papillomaviral infections from high-grade cervical intraepithelial neoplasia. Am J Obstet Gynecol 1985;153:611-8.
11. Kelsey JL, Whittemore AS, Evans AS, Thompson WD. Methods in observational epidemiology. 2nd ed. New York: Oxford University Press; 1996.
12. Wheeler CM, Hunt WC, Schiffman M, Castle PE; Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis 2006;194:1291-9.
13. Pretorius RG, Peterson P, Azizi F, Burchette RJ. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less. Am J Obstet Gynecol 2006;195:1260-5.
14. Chen EY, Tran A, Raho CJ, Birch CM, Crum CP, Hirsch MS. Histological 'progression' from low (LSIL) to high (HSIL) squamous intraepithelial lesion is an uncommon event and an indication for quality assurance review. Mod Pathol 2010;23:1045-51.
15. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92.
16. Walker JL, Wang SS, Schiffman M, Solomon D; ASCUS LSIL Triage Study Group. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). Am J Obstet Gynecol 2006;195:341-8.
17. Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, et al. HPV co-factors related to the development of cervical cancer: results from a populationbased study in Costa Rica. Br J Cancer 2001;84:1219-26.
18. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-91.
19. Stankiewicz E, Prowse DM, Ng M, Cuzick J, Mesher D, Hiscock F, et al. Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One 2011;6:e17517.
20. Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J, et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 2011;224:484-95.
21. Abba MC, Villaverde LM, Gomez MA, Dulout FN, Laguens MR, Golijow CD. The p53 codon 72 genotypes in HPV infection and cervical disease. Eur J Obstet Gynecol Reprod Biol 2003;109:63-6.